To access this element change to forms mode OFF
Grant Award View - GA279589
Novel biomarkers and drug targets for pharmacoresistant epilepsy
GA ID:
GA279589
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2026
Value (AUD):
$2,001,205.48
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Novel biomarkers and drug targets for pharmacoresistant epilepsy
Purpose:
In one-third of epilepsy patients, currently available antiepileptic drugs (AEDs) do not control seizures. Recurrent seizures threaten life and impair its quality; hence, there is a clear need to discover new AEDs. In addition, there is currently no way to accurately predict which and how individuals will respond to a specific or any AED. The proposed research aims identify new AED targets and predict the right (and wrong) drugs for an epilepsy patient from the outset.
GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2018997
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Queensland University of Technology
Recipient ABN:
83 791 724 622
Grant Recipient Location
Suburb:
Brisbane City
Town/City:
Brisbane City
Postcode:
4000
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, QLD, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, NETHERLANDS